GNRH1 and prostate cancer: Androgen deprivation therapy (ADT) is the cornerstone of treatment for hormone-sensitive advanced prostate cancer, which is usually achieved with the use of gonadotrophic-releasing hormone (GnRH) analogs [1,2].